Duration: (29:39) ?Subscribe5835 2025-02-26T10:17:12+00:00
Numinus CEO Discussion: a LEADER in Psychedelic-Assisted Therapy? ( NUMI / LKYSF Stock)
(31:6)
Numinus CEO Payton Nyquvest talks Psychedelics and Mental Health
(3:54)
Numinus CEO on Potential Psychedelic Run
(37:7)
Numinus CEO Provides End of Summer Company Update
(29:39)
EXCLUSIVE shareholder webinar with Numinus Wellness Founder and CEO Payton Nyquvest
(50:7)
Numinus CEO Payton Nyquvest at Psychedelic Capital, Oct 2020 | Microdose
(14:52)
Numinus CEO Discusses Latest Earnings - TDR Exclusive
(20:59)
Numinus Inc.CEO Talks NASDAQ Ambitions
(17:22)
Dinars in 11.1.5! Undermined Dev Interview with Ion Hazzikostas and Maria Hamilton
(13:50)
The Entities that Exist Within Psychedelics | With Dennis McKenna
(12:41)
Cramer: This biotech stock could be worth over $100 billion on an FDA approval
(5:19)
Psychedelics, stigma, science and startups | High Agency | Episode 13
(59:3)
BC Decriminalizes Hard Drugs | Trade To Black
(39:21)
Upcoming Catalysts in the Industry Explained - TDR Exclusive
(34:32)
BREAKING NEWS: MAPS Publishes Phase 3 PTSD Results | The Dales Report
(33:10)
SPOTLIGHT IN FOCUS - The Rise of Psychedelic Therapy
(33:13)
Numinus Outlines 2023 Strategy - Trade To Black
(36:)
An In-depth Review Of Numinus Q1 Results
(26:10)
Numinus Wellness CEO Interview
(28:16)
Numinus Completes Novamind Acquisition | CEO Payton Nyquvest
(14:13)
Numinus CEO: Current State of Psychedelic Industry
(26:46)
Numinus CEO: Psychedelics Benefit From \
(19:2)
Numinus At The Forefront of MDMA | Payton Nyquvest - CEO Numinus Wellness
(16:5)
Numinus Wellness Inc., Payton Nyquvest, CEO \u0026 Chairman
(9:34)
Numinus Wellness to Acquire Novamind: An Interview with Numinus Co-Founder and CEO, Payton Nyquvest
(17:30)
Numinus And MAPS Partnership Explained - TDR Exclusive
(29:7)
A Magic Mushroom Company to be Psyched About | Numinus Wellness(NUMI)
(11:21)
Psychedelics Numinus CEO Shares Why We Need This For Mental Health #shorts
(31)
Numinus CEO Payton Nyquvest Gives RTO Update
(2:54)